메뉴 건너뛰기




Volumn 69, Issue 10, 2012, Pages 1255-1258

Potential use of γ-secretase modulators in the treatment of Alzheimer disease

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; FLURBIPROFEN; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; SEMAGACESTAT;

EID: 84867383173     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2012.540     Document Type: Short Survey
Times cited : (23)

References (9)
  • 1
    • 0019394333 scopus 로고
    • Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia
    • Mabuchi H, Haba T, Tatami R, et al. Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia. N Engl J Med. 1981;305 (9):478-482. (Pubitemid 11047414)
    • (1981) New England Journal of Medicine , vol.305 , Issue.9 , pp. 478-482
    • Mabuchi, H.1    Haba, T.2    Tatami, R.3
  • 2
    • 13944276825 scopus 로고    scopus 로고
    • Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
    • DOI 10.1016/j.cell.2005.02.008
    • Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 2005;120(4):545-555. (Pubitemid 40269768)
    • (2005) Cell , vol.120 , Issue.4 , pp. 545-555
    • Tanzi, R.E.1    Bertram, L.2
  • 3
    • 19944431428 scopus 로고    scopus 로고
    • Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897
    • Anderson JJ, Holtz G, Baskin PP, et al. Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897. Biochem Pharmacol. 2005;69(4): 689-698.
    • (2005) Biochem Pharmacol , vol.69 , Issue.4 , pp. 689-698
    • Anderson, J.J.1    Holtz, G.2    Baskin, P.P.3
  • 4
    • 0033535504 scopus 로고    scopus 로고
    • A presenilin- 1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
    • De Strooper B, Annaert W, Cupers P, et al. A presenilin- 1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature. 1999;398(6727):518-522.
    • (1999) Nature , vol.398 , Issue.6727 , pp. 518-522
    • De Strooper, B.1    Annaert, W.2    Cupers, P.3
  • 5
    • 53749105377 scopus 로고    scopus 로고
    • Presenilins: Members of the γ-secretase quartets, but part-time soloists too
    • Wakabayashi T, De Strooper B. Presenilins: members of the γ-secretase quartets, but part-time soloists too. Physiology (Bethesda). 2008;23:194-204.
    • (2008) Physiology (Bethesda) , vol.23 , pp. 194-204
    • Wakabayashi, T.1    De Strooper, B.2
  • 7
    • 72549105935 scopus 로고    scopus 로고
    • Tarenflurbil Phase 3 Study Group. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: A randomized controlled trial
    • Green RC, Schneider LS, Amato DA, et al; Tarenflurbil Phase 3 Study Group. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA. 2009;302(23):2557-2564.
    • (2009) JAMA , vol.302 , Issue.23 , pp. 2557-2564
    • Green, R.C.1    Schneider, L.S.2    Amato, D.A.3
  • 8
    • 77956311201 scopus 로고    scopus 로고
    • Modulation of γ-secretase reduces γ-amyloid deposition in a transgenic mouse model of Alzheimer's disease
    • Kounnas MZ, Danks AM, Cheng S, et al. Modulation of γ-secretase reduces γ-amyloid deposition in a transgenic mouse model of Alzheimer's disease. Neuron. 2010;67(5):769-780.
    • (2010) Neuron , vol.67 , Issue.5 , pp. 769-780
    • Kounnas, M.Z.1    Danks, A.M.2    Cheng, S.3
  • 9
    • 70350462583 scopus 로고    scopus 로고
    • Begacestat (GSI-953): A novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein γ-secretase for the treatment of Alzheimer's disease
    • Martone RL, Zhou H, Atchison K, et al. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein γ-secretase for the treatment of Alzheimer's disease. J Pharmacol Exp Ther. 2009;331(2):598-608.
    • (2009) J Pharmacol Exp Ther , vol.331 , Issue.2 , pp. 598-608
    • Martone, R.L.1    Zhou, H.2    Atchison, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.